title: SGLT1 does compensate for SGLT2 inhibition.
authors.affiliation: Department of Endocrinology, Hospitales San Roque, Las Palmas de Gran Canaria, Las Palmas, Spain martinez.martin@doctor.com dr.j.martinez@doctor.com.
authors.forename: Francisco Javier
authors.initials: FJ
authors.lastname: Martinez-Martin
authors.affiliation: Medical Affairs, Boehringer Ingelheim Spain, Barcelona, Spain.
authors.forename: Natalia
authors.initials: N
authors.lastname: Jimenez-Martin
authors.affiliation: Department of Nephrology, Hospital Dr. Negrín, Las Palmas de Gran Canaria, Las Palmas, Spain.
authors.forename: Nery
authors.initials: N
authors.lastname: Sablon-Gonzalez
mesh_terms: D003924:Diabetes Mellitus, Type 2; D005947:Glucose; D007004:Hypoglycemic Agents; D007668:Kidney; D051269:Sodium-Glucose Transporter 1; D051297:Sodium-Glucose Transporter 2
chemical_list: D007004:Hypoglycemic Agents; D051269:Sodium-Glucose Transporter 1; D051297:Sodium-Glucose Transporter 2; D005947:Glucose